Last update 25 Mar 2025

Ordesekimab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Anti-IL-15 MAB, HuMax anti-IL15, AMG 714
+ [5]
Target
Action
inhibitors
Mechanism
IL-15 inhibitors(Interleukin-15 inhibitors)
Active Indication
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
VitiligoPhase 2
United States
11 Dec 2020
VitiligoPhase 2
United States
11 Dec 2020
Celiac DiseasePhase 2
United States
24 Aug 2020
Celiac DiseasePhase 2
Canada
24 Aug 2020
Celiac DiseasePhase 2
Netherlands
24 Aug 2020
Celiac DiseasePhase 2
Spain
24 Aug 2020
Enteropathy-Associated T-Cell LymphomaPhase 2
United States
13 Apr 2016
Enteropathy-Associated T-Cell LymphomaPhase 2
Finland
13 Apr 2016
Enteropathy-Associated T-Cell LymphomaPhase 2
France
13 Apr 2016
Enteropathy-Associated T-Cell LymphomaPhase 2
Netherlands
13 Apr 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
-
bfjfrtwfml(fprienjvfs) = did not meet primary or secondary endpoints. qsarmpmyji (ttwiopyemm )
Not Met
Negative
04 Feb 2025
Placebo
Phase 2
28
(AMG 714)
poxxxouliy(qvbnacjssz) = nlzfcshnyq pczuctbsng (djffvmblpe, 8.83)
-
27 Dec 2019
Placebo
(Placebo)
poxxxouliy(qvbnacjssz) = uartiwskxf pczuctbsng (djffvmblpe, 11.70)
Phase 2
64
Placebo Gluten Challenge+AMG 714
(AMG 714 150 mg)
zlnsvveqcs(ljhfuihjgw) = txtfnaphbf damlycifnr (anuwowfbln, 5.39)
-
03 Dec 2019
Placebo Gluten Challenge+AMG 714
(AMG 714 300 mg)
zlnsvveqcs(ljhfuihjgw) = bmtqjxjkga damlycifnr (anuwowfbln, 4.83)
Phase 2
180
AMG 714 280 mg
tgbggskzck(omuazaymya) = aepyduwfom gjlzntdoeo (wynhppqkgx )
Positive
21 Jun 2006
Placebo
tgbggskzck(omuazaymya) = elrnbywmim gjlzntdoeo (wynhppqkgx )
Phase 1/2
-
uetlcmubib(opncucmnwo) = ickltbxuyz vgpbbunfqr (aqjsnthtso )
-
18 Jun 2003
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free